Anbio Biotechnology (NNNN) Assets Average (2024 - 2025)
Anbio Biotechnology (NNNN) posted quarterly Assets Average of $13840.3 billion for Q4 2025, up 79694093.8% year-over-year from N/an in Q4 2024, and little changed quarter-over-quarter from $13840.3 billion in Q2 2025.
Anbio Biotechnology (NNNN) Assets Average (2024 - 2025) Analysis & Trends
Anbio Biotechnology (NNNN) has reported Assets Average for 2 consecutive years, with $13840.3 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average rose 79694093.8% year-over-year to $13840.3 billion; the TTM figure through Dec 2025 stood at $13840.3 billion (up 79694093.8% YoY), while the FY2025 annual figure was $24.6 million, up 41.55% from the prior year.
- Assets Average held at $13840.3 billion in Q4 2025 per NNNN's latest filing, from $13840.3 billion in the prior quarter.
- Across five years, Assets Average topped out at $13840.3 billion in Q4 2025 and bottomed at $17.4 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 20.49 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 50.78 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 31.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 8.88 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 39.18 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.09 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 14.17 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 12.45 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 19.82 Bn |
| 10 | Anbio Biotechnology | 301.77 Mn | 289.87 Mn | - | 13,840.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13,840.31 Bn |
| Jun 30, 2025 | 13,840.31 Bn |
| Dec 31, 2024 | 17.37 Mn |